Amundi’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
88,261
-10,052
-10% -$232K ﹤0.01% 1165
2026
Q1
$2.35M Buy
98,313
+49,608
+102% +$1.21M ﹤0.01% 1075
2025
Q4
$1.1M Buy
+48,705
New +$1.06M ﹤0.01% 1253
2025
Q2
Sell
-540
Closed -$5.25K 1819
2025
Q1
$5.25K Buy
540
+137
+34% +$1.55K ﹤0.01% 1915
2024
Q4
$4.66K Buy
+403
New +$5.27K ﹤0.01% 1945
2023
Q3
Sell
-2,519,102
Closed -$25.3M 2022
2023
Q2
$25.3M Sell
2,519,102
-13,473,812
-84% -$125M 0.01% 655
2023
Q1
$141M Sell
15,992,914
-4,233,910
-21% -$49.9M 0.08% 272
2022
Q4
$270M Sell
20,226,824
-1,962,877
-9% -$24.5M 0.15% 157
2022
Q3
$283M Buy
22,189,701
+6,618,586
+43% +$116M 0.17% 147
2022
Q2
$305M Buy
15,571,115
+1,313,013
+9% +$31.1M 0.25% 108
2022
Q1
$379M Sell
14,258,102
-550,059
-4% -$14.6M 0.26% 99
2021
Q4
$401M Buy
14,808,161
+516,184
+4% +$16.1M 0.25% 97
2021
Q3
$456M Buy
14,291,977
+1,985,388
+16% +$66.6M 0.32% 64
2021
Q2
$427M Buy
+12,306,589
New +$406M 0.3% 72

Other funds holding ELAN

Amundi's ELAN Position: Q2 2026 in Review

Amundi reduced its Elanco Animal Health (ELAN) stake by 10% in Q2 2026, selling an estimated $232K and leaving 88,261 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Amundi first reported a position in ELAN in Q2 2021 and has held it in 14 quarters since. The position peaked at $456M in Q3 2021. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Amundi held 88,261 shares of Elanco Animal Health worth $2.17M as of Q2 2026.
  • Amundi sold 10,052 Elanco Animal Health shares in Q2 2026, an estimated $232K.
  • Elanco Animal Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1165 holding.
  • Amundi first reported a position in Elanco Animal Health in Q2 2021 and has held it in 14 quarters since.
  • Amundi's Elanco Animal Health position peaked at $456M in Q3 2021.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.